The estimated Net Worth of David Bailey is at least $34.8 million dollars as of 21 August 2009. David Bailey owns over 47,766 units of Staar Surgical Co stock worth over $34,183,618 and over the last 20 years David sold STAA stock worth over $641,992.
David has made over 12 trades of the Staar Surgical Co stock since 2005, according to the Form 4 filled with the SEC. Most recently David sold 47,766 units of STAA stock worth $154,284 on 21 August 2009.
The largest trade David's ever made was selling 47,766 units of Staar Surgical Co stock on 21 August 2009 worth over $154,284. On average, David trades about 11,980 units every 78 days since 2005. As of 21 August 2009 David still owns at least 1,127,800 units of Staar Surgical Co stock.
You can see the complete history of David Bailey stock trades at the bottom of the page.
David's mailing address filed with the SEC is 1911 WALKER AVENUE, , MONROVIA, CA, 91016.
Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal... et Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
Staar Surgical Co executives and other stock owners filed with the SEC include: